Advocacy out of the lab

A researcher’s motivation to address the bast unmet need in neuroscience.

The latest Lundbeck news

Visit our Newsroom for the latest Lundbeck US news, insights and updates.

This is Lundbeck

We are one of the only biopharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.

About us

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Our science

A better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person and community behind the disease.

Our focus

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

Mara Formentini on working at Lundbeck

Bringing your whole self to work and its rewards

See all stories

We are Lundbeck

In the U.S., we have approximately 1,000+ colleagues working tirelessly to advance neuroscience, deliver new and innovative treatments and support patient communities. 

Lundbeck in the U.S.